When the positivity of CLTC was defined as stronger CLTC immunoreactivity in carcinoma cells versus their adjacent non-neoplastic epithelial cells, CLTC status was positive in 7 of 10 ER-positive breast carcinomas that we examined in the additional analysis (70%). This evidence concerns the gene ESR1 and breast carcinoma.